Home » Topics » Briefs » Other news to note

Other news to note
RSS

Traversa Therapeutics' Series B financing to fund RNAi oncology programs

April 7, 2009

BTG presents update on clinical development activities for year ended March 2009

April 7, 2009

Pfizer provides pipeline update in high-priority disease areas

April 7, 2009

StemCells acquires Stem Cell Sciences

April 6, 2009

CV Technologies changes name to Afexa Life Sciences as part of rebranding plan

April 6, 2009

Bayer HealthCare and Genzyme sign new strategic agreement

April 3, 2009

NeuroSearch presents update on clinical development programs

April 2, 2009

Ligand and GlaxoSmithKline collaboration identifies new lead compound

April 2, 2009

Affitech shareholders approve proposed merger with Pharmexa

April 1, 2009

Fourth quarter highlights at Merck KGaA

March 31, 2009

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...